tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gil Blum, 294 are a BUY (98.66%), 4 are a HOLD (1.34%).
Analyst Gil Blum, currently employed at NEEDHAM, carries an average stock price target met ratio of 23.67% that have a potential upside of 55.95% achieved within 118 days. Previously, Gil Blum worked at TRUIST.
Gil Blum’s has documented 567 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GERN, Geron at 13-Dec-2024.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for GTHX (G1 THERAPEUTICS) at 6/25/2024. The price target of $6 was fulfilled within 43 days with a profit of $3.8 (172.73%) receiving and performance score of 40.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2
$0.6 (42.86%)
1 years 11 days ago
(18-Dec-2023)
0/2 (0%)
$0.7 (53.85%)
Buy
$2
$0.6 (42.86%)
$36
1 years 5 months 16 days ago
(13-Jul-2023)
0/2 (0%)
$0.59 (41.84%)
Hold
$2
$0.6 (42.86%)
$2
1 years 5 months 17 days ago
(12-Jul-2023)
1/3 (33.33%)
$0.57 (39.86%)
7
Buy
2 years 22 days ago
(07-Dec-2022)
0/2 (0%)
$13.44 (140.59%)
Buy
2 years 7 months 12 days ago
(17-May-2022)
0/1 (0%)
$19.05 (212.85%)
Which stock is Gil Blum is most bullish on?
Which stock is Gil Blum is most reserved on?
What Year was the first public recommendation made by Gil Blum?
